Products
Tools
Education
$3.95
$3.53
$3.83
$1.39
$167.1M
104.89%
This is a preview of the full version of Prosperse
Checkpoint Therapeutics, a clinical-stage immunotherapy and targeted oncology company, announced that its President and CEO will present a corporate overview at the H.C. Wainwright 26th Annual Global Investment Conference on September 10, 2024.
N/A
Sep 4, 2024
Date: Oct 25, 2024
Date: Oct 24, 2024